Ankur Singla

Ankur Singla

Auto-generated profile, based on publicly available information

Ankur Singla

Department of Internal Medicine Northwest Health‐Porter Valparaiso Indiana USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2025 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
PDF file
MMManeeth Mylavarapu
Maneeth Mylavarapu
LPLakshmi Sravya Popuri
Lakshmi Sravya Popuri
NTNiharika Tanwar
Niharika Tanwar
ASAnkur Singla
Ankur Singla
FZFabeha Zafar
Fabeha Zafar
SDSara Cherkos Dawit
Sara Cherkos Dawit

1 March 2022 in Indian Dermatology Online Journal
Verified
Journal Article
Open access
PDF file
ABAditi Bansal
Aditi Bansal
ASAnkur Singla
Ankur Singla
ASAminder Anthony Singh
Aminder Anthony Singh
SKSukhjot Kaur
Sukhjot Kaur
Pyoderma gangrenosum is a rare, chronic neutrophilic dermatosis of unknown etiology. The classical clinical feature of pyoderma gangrenosum is a pustule or plaque that rapidly progresses to a painful, necrotic ulcer with undermined violaceous margins. Pyoderma gangrenosum may be associated with underlying inflammatory bowel diseases, hematological malignancies, or rheumatologic disorders in 50–70% of the cases. The visceral involvement by pyoderma gangrenosum is rare. Sterile neutrophilic infiltrates in organs other than the skin are uncommon systemic manifestations of neutrophilic dermatoses, but have occasionally been reported. We report a case of a 38-year-old female with pyoderma gangrenosum and visceral involvement manifesting as splenic abscess.

15 January 2024 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
DRDiviya Bharathi Ravikumar
Diviya Bharathi Ravikumar
BSBarath Prashanth Sivasubramanian
Barath Prashanth Sivasubramanian
ASAnkur Singla
Ankur Singla
RVRakshaya Venu
Rakshaya Venu
SSSaketh Palasamudram Shekar
Saketh Palasamudram Shekar
Introduction: Extrapulmonary tuberculosis (EPTB) adds to India’s significant economic burden, with pericardial effusion being a potentially fatal complication. This case report highlights the need for early diagnosis and the feasibility of shorter-duration treatment for EPTB in developing countries. Presentation: This case report describes a 19-year-old male from Southeast Asia who had a history of bronchiectasis involving the left lower lobe and the right middle lobe, which was cystic in nature, as well as multiple episodes of non-tuberculous pneumonia. Currently, he presented with fever, hypotension, tachycardia, and acute kidney injury. Echocardiogram showed left ventricular dysfunction with a left ventricular ejection fraction (LVEF) of 45% and moderate pericardial effusion. Early signs of cardiac tamponade were noted, specifically the absence of respiratory variation in the right ventricle and left ventricle collapse. Emergent pericardiocentesis was performed, and hemorrhagic pericardial fluid was aspirated. Fluid analysis revealed high levels of LDH (5000 U/L), polymorphonuclear leukocytosis, and acid-fast bacilli that were visualized on microscopy, which led to the diagnosis of pericardial tuberculosis. A CT of the abdomen showed hepatosplenomegaly and polyserositis. Empirically, antitubercular therapy consisting of isoniazid, rifampin, pyrazinamide, and ethambutol was administered for 2 months and isoniazid along with rifampicin was given for the next 4 months. Serial echocardiograms in the following months showed an improvement in LVEF (55%) and decreased effusion. However, during this treatment period, due to frequent episodes of pneumonia, the evaluation of immunodeficiency disorders was performed and revealed low levels of IgG (4.741 g/L), IgA (0.238 g/L), and IgM (0.098 g/L). He was diagnosed with common variable immunodeficiency disease and received intravenous immunoglobulin therapy. Conclusion: This report emphasizes the timely identification of cardiac tamponade and the effective management of EPTB through a shorter-than-recommended course of antitubercular therapy, resulting in the alleviation of symptoms and better overall health outcomes.

18 June 2026 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
STShubam Trehan
Shubam Trehan
AZAhmed G. Zedan
Ahmed G. Zedan
AMAlejandro Vidal Margenat
Alejandro Vidal Margenat
GBGaurav Bector
Gaurav Bector
RHRamesh Hariharan
Ramesh Hariharan
ASAnkur Singla
Ankur Singla

28 January 2026 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
AAAli Al-Shammari
Ali Al-Shammari
ASAnkur Singla
Ankur Singla
ARAdishwar Rao
Adishwar Rao
ASAhmed Sermed Al Sakini
Ahmed Sermed Al Sakini
AAAmeer Awashra
Ameer Awashra
KAKeerat Rai Ahuja
Keerat Rai Ahuja

23 December 2023 in Journal of Cardiology Cases
Verified
Journal Article
Open access
ASAnkur Singla
Ankur Singla
AGArchana Gautam
Archana Gautam
AGAmandeep Goyal
Amandeep Goyal
TDTarun Dalia
Tarun Dalia
Ebstein's anomaly (EA), a congenital cardiac anomaly, is characterized by apical displacement of the tricuspid valve leaflet(s) into the right ventricle. We present the case of a 61-year-old female with a history of EA, Wolff-Parkinson-White syndrome, and patent foramen ovale (PFO), who presented with worsening hypoxia and confusion, in the setting of left lower extremity cellulitis and abscess. The computed tomography (CT) scan of the head showed a cerebellar infarct with hemorrhagic conversion. Magnetic resonance imaging of the head showed a satellite lesion raising concern for the embolic nature of infarcts. After ruling out cardioembolic causes of cerebellar infarction, her presenting symptoms were attributed to paradoxical septic emboli from the left leg abscess (demonstrated on CT scan of the leg). She was deemed a poor candidate for surgical closure of PFO due to contraindication to use heparin (due to the presence of hemorrhagic stroke) and underlying comorbidities. Septic embolization is a rare but dreaded complication in EA patients with PFO. • Paradoxical emboli can occur in patients with Ebstein's anomaly (EA) and patent foramen ovale (PFO). • The mainstay of management in case of paradoxical embolism lies with the identification and treatment of the underlying cause, such as infective endocarditis, deep vein thrombosis, or infectious source, as in the present case. • The surgical correction of PFO in EA patients should be considered when the patient becomes symptomatic with cyanosis, hypoxia, or manifestations of paradoxical emboli.